MedTrace Logo

Clinical, Oncologic, and Metabolic Effects of Pancreatic Mass Loss After Pancreatectomy in Non-Diabetic Patients

NCT07608055 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 579

Last updated 2026-05-27

No results posted yet for this study

Summary

This study will examine how removal of part or all of the pancreas affects blood sugar control, metabolism, and clinical outcomes over time.

The study will include adults without diabetes before surgery who undergo pancreatic surgery as part of routine clinical care at Fondazione Policlinico Universitario A. Gemelli IRCCS.

Researchers will study whether participants develop diabetes after surgery and whether this risk changes according to the type of pancreatic resection.

Information from routine clinical care, metabolic tests, imaging, and pancreatic tissue samples collected during surgery may be used for research analyses.

Conditions

  • Pancreatectomy
  • Diabetes Mellitus Type 2
  • Pancreatic Neoplasms

Sponsors & Collaborators

  • European Foundation for the Study of Diabetes

    collaborator OTHER

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    lead OTHER

Principal Investigators

  • Teresa Mezza · Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-31
Primary Completion
2037-05-31
Completion
2041-05-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07608055 on ClinicalTrials.gov